Skip to main content
Clinical Trials/NCT05095142
NCT05095142
Completed
Not Applicable

Preventive and Personalized Medicine (2021-2023)

Asfendiyarov Kazakh National Medical University1 site in 1 country500 target enrollmentMarch 30, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Idiopathic Osteoarthritis
Sponsor
Asfendiyarov Kazakh National Medical University
Enrollment
500
Locations
1
Primary Endpoint
enotyping for the SNP associated with liver cirrhosis
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to identify genetic determinants of susceptibility to idiopathic osteoarthritis of the knee . It will assist in predicting individual risks of disease progression and would help to clarify pathophysiologic mechanisms of idiopathic osteoarthritis of the knee

Registry
clinicaltrials.gov
Start Date
March 30, 2022
End Date
January 20, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Asfendiyarov Kazakh National Medical University
Responsible Party
Principal Investigator
Principal Investigator

Ildar Fakhradiyev

Head of the Laboratory of Experimental Medicine

Asfendiyarov Kazakh National Medical University

Eligibility Criteria

Inclusion Criteria

  • Patients with bilateral idiopathic gonarthrosis aged 18 to 65 years;
  • Representatives of the Kazakh ethnic group up to the 3rd generation;
  • Hereditary history of arthrosis;
  • Persons who are able and willing to provide written informed consent;

Exclusion Criteria

  • Patients with bilateral idiopathic gonarthrosis under 18 years of age and over 65 years of age;
  • Representatives of other ethnic groups;
  • Representatives of the Kazakh ethnic group less than 3 generations;
  • No family history of bilateral idiopathic gonarthrosis;
  • Patients with an acute period of the inflammatory process (laboratory and clinical signs);
  • Persons who, in the opinion of the researcher, are mentally or legally incapacitated, which prevents obtaining informed consent;
  • Pregnant or lactating women;
  • Tuberculosis of any localization in the active phase and in history;
  • Severe and decompensated diseases of the liver and kidneys, cardiovascular system;
  • Severe and decompensated course of endocrine diseases;

Outcomes

Primary Outcomes

enotyping for the SNP associated with liver cirrhosis

Time Frame: 1 year

Genotype frequency of SNP in the study genes of participants and control participants.

Study Sites (1)

Loading locations...

Similar Trials